Swiss All Share Index
15.070,92
PKT
-30,75
PKT
-0,20
%
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.11.23 | UBS Underweight | Barclays Capital | |
| 07.11.23 | UBS Outperform | RBC Capital Markets | |
| 07.11.23 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 07.11.23 | UBS Buy | Goldman Sachs Group Inc. | |
| 07.11.23 | UBS Overweight | JP Morgan Chase & Co. | |
| 07.11.23 | UBS Buy | Deutsche Bank AG | |
| 06.11.23 | Swiss Re Sell | UBS AG | |
| 06.11.23 | Swiss Re Hold | Deutsche Bank AG | |
| 03.11.23 | Swiss Re Sector Perform | RBC Capital Markets | |
| 03.11.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 03.11.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 03.11.23 | Swiss Re Sector Perform | RBC Capital Markets | |
| 03.11.23 | Swiss Re Sell | UBS AG | |
| 03.11.23 | Swiss Re Hold | Jefferies & Company Inc. | |
| 02.11.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 02.11.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 02.11.23 | Nestlé Buy | Deutsche Bank AG | |
| 01.11.23 | ams-OSRAM Hold | Jefferies & Company Inc. | |
| 01.11.23 | ams-OSRAM Hold | Deutsche Bank AG | |
| 01.11.23 | Roche Sell | Deutsche Bank AG | |
| 01.11.23 | ams-OSRAM Underweight | Barclays Capital | |
| 01.11.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 31.10.23 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
| 31.10.23 | ams-OSRAM Hold | Jefferies & Company Inc. | |
| 31.10.23 | DocMorris Hold | Deutsche Bank AG | |
| 31.10.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 30.10.23 | Roche Equal Weight | Barclays Capital | |
| 30.10.23 | Givaudan Sell | UBS AG | |
| 27.10.23 | ams-OSRAM Hold | Jefferies & Company Inc. | |
| 27.10.23 | Zurich Insurance Overweight | Barclays Capital | |
| 27.10.23 | Swiss Re Equal Weight | Barclays Capital | |
| 26.10.23 | Novartis Buy | Deutsche Bank AG | |
| 24.10.23 | Novartis Neutral | UBS AG | |
| 24.10.23 | Novartis Buy | Jefferies & Company Inc. | |
| 24.10.23 | Richemont Buy | Jefferies & Company Inc. | |
| 23.10.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 23.10.23 | Novartis Underweight | Barclays Capital | |
| 23.10.23 | Richemont Buy | UBS AG | |
| 23.10.23 | Roche Neutral | UBS AG | |
| 23.10.23 | Roche Underweight | JP Morgan Chase & Co. |